| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 770 | $90 | $69.4K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 390 | $180 | $68.9K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 330 | $130 | $44.6K |
| J0897 | Injection, denosumab, 1 mg | 2,340 | $20 | $44.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 260 | $140 | $35.5K |
| 99490 | The clinical staff provides services directed by the provider to support and coordinate a patient’s care across multiple disciplines. The patient has two or more chronic conditions that place the… | 700 | $40 | $30.9K |
| J9030 | BCG live intravesical instillation, 1 mg | 13,950 | $1 | $27.9K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 330 | $70 | $21.9K |
| J9155 | Injection, degarelix, 1 mg | 4,160 | $1 | $12.5K |
| 52235 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 50 | $210 | $11.5K |